source
- Teva says it has time to prepare for upcoming US tariffs on imported generic drugsTeva CEO Richard Francis said the company believes it has sufficient time to prepare for the tariffs the Trump administration is considering on generic drugs imported from outside the United States…
- Two biotech firms announce reverse mergers to list experimental bispecific antibody and BTK inhibitor on NasdaqTwo biotech companies have each entered reverse merger agreements to become publicly traded on Nasdaq. One firm, based in China, is developing a bispecific antibody and will use the merger to brin…